Well, in case Abbvie wishes to buy enanta, the negotiations just got simpler with this new development. No 3rd party to account for.
OTOH, with JNJ out of the loop with yesterday acquisition of Alios, and NVS allegedly out of the HepC biz (or so they say) which BPs are left to gobble up Achn I wonder ? I can't think of any .